New hope for rare blood cancer: venetoclax trial launches in japan

NCT ID NCT07387471

First seen Feb 04, 2026 · Last updated May 14, 2026 · Updated 17 times

Summary

This study tests a drug called venetoclax in about 14 adults in Japan who have a rare blood cancer (Waldenström macroglobulinemia) that has returned or not responded to prior therapy. Participants take venetoclax pills daily for up to 28 months. The goal is to see if the drug can shrink or control the cancer. This is not a cure, as ongoing management is expected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOPLASMACYTIC LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chiba Cancer Center /ID# 279177

    RECRUITING

    Chiba, 260-0801, Japan

  • Gunma University Hospital /ID# 277576

    RECRUITING

    Maebashi, Gunma, 371-8511, Japan

  • Kindai University Hospital /ID# 277587

    RECRUITING

    Sakai-shi, Osaka, 590-0197, Japan

  • NHO Mito Medical Center /ID# 279175

    RECRUITING

    Higashiibaraki-gun, Ibaraki, 311-3193, Japan

  • Nagoya City University Hospital /ID# 277580

    RECRUITING

    Nagoya, Aichi-ken, 467-8602, Japan

  • National Cancer Center Hospital /ID# 279076

    RECRUITING

    Chuo-Ku, Tokyo, 104-0045, Japan

  • National Hospital Organization Disaster Medical Center /ID# 277741

    RECRUITING

    Tachikawa, Tokyo, 190-0014, Japan

  • The University of Tokyo Hospital /ID# 279174

    RECRUITING

    Bunkyo-ku, Tokyo, 113-8654, Japan

  • University Hospital Kyoto Prefectural University of Medicine /ID# 277584

    RECRUITING

    Kyoto, Kyoto, 602-8566, Japan

  • University of Fukui Hospital /ID# 279173

    RECRUITING

    Yoshida-gun, Fukui, 910-1104, Japan

  • University of Yamanashi Hospital /ID# 279179

    RECRUITING

    Chuo-shi, Yamanashi, 409-3898, Japan

Conditions

Explore the condition pages connected to this study.